Dewpoint Therapeutics’ $480 Million Collaboration with MTPC

Wilson Sonsini Goodrich & Rosati represented Dewpoint Therapeutics in the transaction.Dewpoint Therapeutics Inc., the leading biotechnology company that develops therapeutics by targeting biomolecular condensates, announced that…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here